Publication | Closed Access

Early benefit assessment of new drugs in Germany – Results from 2011 to 2012

PharmacotherapyDrug AssessmentHarm ReductionPre-clinical PharmacologyPreventive MedicineAddiction MedicineDrug MonitoringHealth Services ResearchHealth SciencesDrug SafetyEarly Benefit AssessmentHealth PolicyOutcomes ResearchNew DrugsPharmacoeconomicsGermany – ResultsPharmacologySubstance AbuseHealth EconomicsDrug TrialMedicinePharmacoepidemiology